The trial was shorter than Eli Lilly's, 64 weeks, and the company noted that the pill was used with a reduced-calorie diet and increased physical activity
Drivers of Growth in GLP-1 Nutritional Support The demand for GLP-1 nutritional support is fueled by the increasing prevalence of obesity and type 2 diabetes, which affects over 30% of the global population
With proper prevention and personalized care, most patients can maintain healthy, even-toned skin while benefiting from metabolic therapy
Similarly, people's bodies can adjust to GLP-1 doses, meaning the drug becomes less effective over time and the dose must be nudged to produce the desired amount of "hunger noise" reduction
Some experience lingering mild symptoms at higher doses
Make sure you leave with one of their skincare products